Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
to decode and harness noncoding variant contributors to cardiomyopathy. We have also developed two new mouse models for translational discovery and testing of gene therapy approaches (novel haploinsufficient
-
Leibniz-Institute for Food Systems Biology at the Technical University of Munich | Freising, Bayern | Germany | 19 days ago
, combining chemistry, photonics, and molecular biology, and has direct implications for DNA data storage, gene therapy, genome screening, proteomics, and genomics. The goal is to push the limits of DNA
-
undergraduate students. Competitive salaries, space, and start-up packages will be provided. Applicants with particular expertise and emphasis in cell and gene therapies whether using experimental laboratory
-
trials involving innovative therapies such as gene therapy and antisense oligonucleotides. Our multidisciplinary approach ensures comprehensive care for patients and families, while fostering collaboration
-
to: Testing the phage therapy efficacy in humanized mouse model, characterizing the immune responses, safety, toxicity and biodistribution in humanized mice. HIV gene therapy: depending on the interest and
-
of cell and gene therapy for selected rare diseases. We cooperate with the Fraunhofer Institute IZI (Germany), the University of Leipzig (Germany) and the University of Copenhagen (Denmark
-
from blood and redirected toward cancer antigens via gene-engineering with chimeric antigen receptors (CARs) or T cell receptors (TCRs). CAR-T cell therapy has elicited profound responses in
-
with core data analysis and professional skills that are necessary for bioscience research and related non-academic careers. https://www.yorkshirebiosciencedtp.ac.uk Project Description: The highly
-
of the insult, and the cellular and tissue context. The AHR is a ligand-dependent transcription factor implicated in numerous cellular/tissue/organismal functions, including proliferation, differentiation
-
-based genome editing tools into next-generation gene therapies to treat those untreatable human genetic diseases, such as cystic fibrosis and liver cancer. To achieve this, we will engineer advanced